Weekly Recap | XTALPI -2.65%, AI surge overshadowed by headline lossWeekly Review·4 hours ago02228-4.16%
G Sachs Raises CSPC PHARMA TP to HKD12.56, Highlights mRNA VaccinesAASTOCKS News·1 day ago, 03:31 AM01093-3.47%
CSPC Pharmaceutical: Buy Rating Reaffirmed as Earnings Visibility Improves and DCF-Based Target Price Raised to HK$13.44Tip Ranks·14 hours ago01093-3.47%
SBP GROUP Gains 3.6% by Midday; BofAS Raises TP to HKD7.1 and Lifts Earnings ForecastsAASTOCKS News·1 day ago, 11:41 PM01177+3.80%
Sino Biopharm says NMPA clears TQF6422 obesity drug candidate for clinical trialPUBT·22 hours ago01177+3.80%
Daiwa Raises SBP GROUP TP to HKD7.2 as Interim Adjusted NP Far Beats ForecastsAASTOCKS News·2 days ago, 11:21 PM01177+3.80%
Moderna's cancer-vaccine breakthrough drives broad biopharma stock rallyMarketWatch·2 days ago, 07:28 PMLLY+0.88%AMGN+1.88%
Akeso says China NMPA clears Phase I trial for B7-H3 ADC AK157D1 in solid tumorsPUBT·1 day ago, 12:31 AM09926-3.89%
Sino Biopharma rebrands as SBP Group, targets global expansion via direct commercial rollout and partnershipsPUBT·2 days ago, 02:03 AM01177+3.80%
3SBio H1 FY26 net profit rises 26.5% to RMB 1.44 billion; revenue increases 3.9% to RMB 4.53 billionPUBT·1 day ago, 02:25 AM01530+8.06%
